Authors: Deodutta Roy; Jai Parkash; Satya Narayan

Source: Current Pharmacogenomics, Volume 2, Number 4, December 2004 , pp. 379-390(12)

Publisher: Bentham Science Publishers

Abstract:

Mitochondria are important targets of steroid hormone action. The receptors for steroid hormones, including estrogen, thyroxine and glucocorticoid, are present in the mitochondria, while steroid hormone responsive elements are also found in the mitochondrial genome. The presence of the steroid hormone receptors in the mitochondria, transport of ligands to the mitochondria, sequences of hormone response elements in the mitochondrial genome, and modulation of mitochondrial encoded genes by steroid hormones support a direct action of steroid hormones on mitochondrial gene transcription. This is parallel to the primary actions of the steroid hormones on nuclear gene transcription as a mechanism to coordinate regulation of mitochondrial biogenesis by steroid hormones. The cross-talk between the cell nucleus and the mitochondria appears to control steroid hormone-induced signaling involved in the apoptosis, proliferation, and differentiation of both normal and malignant cells. Evaluation of the defects in genetics and physiology of mitochondria, specifically in steroids hormone-related endocrine diseases in humans, suggests that several variants of human endocrine diseases, including cancer, manifest as a result of mitochondrial physiologic and metabolic compensation of genetic defects. The steroidal agents control biogenesis and maintenance of mitochondria through the crosstalk between nuclear and mitochondrial genomes. The regulation of mitochondrial transcription by steroidal hormones, presumably occurring through pathways similar to those that take place in the nucleus, opens a new way to better understand steroid hormone and vitamin action at the cellular level. Therefore, an in-depth analysis of such regulatory mechanisms is pertinent to the development of novel drugs and gene therapy strategies for the treatment of steroid hormone-dependent diseases related to mitochondrial disorders including cancer.

Keywords: steroid hormones; defects in genetics and physiology of mitochondria; human diseases

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1570160043377295

Affiliations: 1: Environmental and Occupational Health program, Robert Stempel School of Public Health, Florida International University, 11200 S.W. 8th Street, Miami, FL 33199,USA.

Publication date: 2004-12-01

More about this publication?

• Current Pharmacogenomics provides comprehensive overviews of all current research on pharmacogenomics and pharmacogenetics. All areas of the field from pre-clinical to clinical research are covered, including related areas such as genomics, proteomics, target discovery, bioinformatics and novel diagnostics. This international journal is peer-reviewed and publishes both mini- and full review articles.
  
  The journal has become essential reading for all researchers and clinicians with interests in pharmacogenomics and pharmacogenetics.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology ,  Genetics
• By this author: Deodutta Roy ;  Jai Parkash ;  Satya Narayan

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers